NOD Pharmaceuticals


They try to develop oral formulations for biopharmaceuticals, including insulin, exenatide, interferon, human growth hormone and more.
NOD Pharmaceuticals is a company that is privately held and their aim is an innocative drug delivery. They use patented platform technology, nanoparticle oral delivery or NOD technology, to develop oral formulations for biopharmaceuticals, including insulin, exenatide, interferon, human growth hormone and more. Their unique attribute of NOD tech allows high efficient oral absorption of bio-drugs and modulation of pharmatokinetic profile, in contrasting to competing technologies.
Business Type: Nanotextile » | Biotechnology » | Electrotechnics » |
NOD Pharmaceuticals338 Galileo Road, 5401, Zhangjiang Hi-Tech Park |
Share with friends:
Nanotechnology in medicine | Nano materials | Nanotechnology electronics | Nano asociation |
Follow Nanotechnology Journal on
© 2008 - 2022 Nanotechnology research | All rights reserved | Developed by Makovic.net